How MAT Works
MAT works by targeting the neurobiological underpinnings of addiction — the cravings, withdrawal symptoms, and dysregulated reward systems that make sustained abstinence so difficult without medical support. FDA-approved medications like buprenorphine and naltrexone bind to opioid receptors in the brain, blocking the euphoric effects of opioids and reducing the physical pull toward use.
This neurobiological stabilization creates the conditions for meaningful therapeutic work. When cravings are managed and withdrawal is controlled, clients can fully engage in counseling, develop coping skills, rebuild relationships, and address the root causes of their addiction.

